For example, it was reported that the CD133+/VEGFR-2+ circulating endothelial progenitor cells are more abundant in patients with glioblastomas compared to low-grade gliomas, and their higher percentage is associated with lower patient survival [189] (Figure 5). The gene discussed is PROM1; the disease is central nervous system cancer.